Evolocumab

Evolocumab

Evolocumab is a human IgG2 monoclonal antibody that binds to human PCSK9 Proprotein Convertase Subtilisin Kexin Type 9).

 

 

[accordions]
[accordion title= “Chemical Properties“]
Molecular Weight 144 kDa
CAS No. 1256937-27-5

[/accordion]

 

 

 

[accordions]
[accordion title= “References and Literature“]

1. Sreeneeranj Kasichayanula, et al. Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor. Clin Pharmacokinet. 2018; 57(7): 769–779.

[/accordion]